Apocynin.
A small plant phenol studied for damping superoxide production at the enzyme that makes it, rather than mopping it up afterwards. Almost all of that work is laboratory and animal.
Reviewed March 2026
- Category
- Compound
What Apocynin is, and what it does.
- Does it work
- Suits people who follow oxidative stress science closely and want the compound behind it. For antioxidant support with human trials behind it, vitamin C, NAC and quercetin are further along.
- How much to take
- 100mg to 300mg a day is the maintenance band on record. The 600mg figure comes from research conditions rather than daily use, and human dosing work on it is scarce.
- Time to feel it
- Nobody has measured a timeline for this in people. Its described action is on an enzyme complex, so any change sits in oxidative stress markers rather than in sensation.
- The first dose
- Day one passes without a signal. There is no taste, no lift and no stimulant edge, and what it acts on sits in oxidative stress measures rather than sensation.
- With regular use
- Weeks of daily use haven't been studied in people. What's on record is laboratory and animal work on lowering superoxide production at the point it's made.
- How well tolerated
- Human safety data is thin, which is the honest headline. Ask a clinician before taking it alongside prescribed medicines, and know there is no long-term human record for it.
- How it feels
- Nobody has measured the subjective experience. Most compounds working at this level are quiet, and this one gives you no taste, no lift and no obvious signal.
- The overlooked benefit
- It's a pro-drug. Peroxidase activity has to switch it on first, so it acts where that activity is abundant, and behaves as a plain antioxidant in cells that lack it.
100 to 300mg a day is where Apocynin works.
Source: Stefanska & Pawliczak Eur J Pharmacol 2008; primarily in vitro/animal data
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Apocynin has emerging evidence. Based on 6856+ studies.
- oxidative stress defenceIn vitro study
- assembly of the NADPH oxidase complexIn vitro study
- nitric oxide dependent vascular responsesAnimal study
- a healthy inflammatory responseAnimal study
- neutrophil superoxide outputIn vitro study
Questions people ask about Apocynin.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Apocynin needs a peroxidase step to form its active dimer and it reacts readily with cellular thiols. Cysteine supply therefore shapes both how much converts and how quickly it is conjugated away.
Apocynin forms conjugates with glutathione, so glutathione status governs how much stays in free circulation. The two are linked through the same thiol chemistry rather than acting on separate targets.
Apocynin acts upstream by limiting NADPH oxidase assembly and the superoxide it generates, while SOD dismutates superoxide that is already formed. They cover the same radical at two different points.
Apocynin is used experimentally to block assembly of the NADPH oxidase complex, cutting superoxide production at the source. Ascorbate works on the other side of the same chemistry by reacting with superoxide once formed and by regenerating other antioxidants. The two act at different points of one pathway, which is why they often appear together in redox experiments. No human trial has tested them as a combination supplement.
Superoxide from NADPH oxidase feeds lipid peroxidation in membranes. Alpha-tocopherol intercepts the propagating lipid peroxyl radical and is itself recycled by ascorbate. Reducing the upstream flux and quenching the downstream chain address different halves of the same process. This is mechanistic reasoning, not a measured combination effect.
Apocynin is a pro-drug: peroxidase activity converts it to a reactive species that conjugates with glutathione and dimerises, and that conversion draws on cellular thiols. Lipoic acid, reduced to dihydrolipoate, helps regenerate glutathione. Thiol status therefore sits between apocynin and its active chemistry, in both directions. The interaction is described in cell work rather than in people.
Activation of apocynin proceeds through a radical intermediate that forms an adduct with glutathione. Cysteine availability sets the ceiling on glutathione synthesis. That makes cysteine supply an upstream determinant of the chemistry apocynin depends on. The requirement is established; a clinical benefit from pairing them is not.
Quercetin is reported to reduce NADPH oxidase activity in cultured cells, and apocynin is the reference tool compound for that same target. Acting on one enzyme complex by different chemistry is a plausible additive pairing on paper. Neither compound has human combination data, and cell concentrations often exceed anything reachable by mouth. Read it as mechanistic rather than clinical.
Vascular cell work pairs oxidase inhibition with polyphenols that shift redox signalling and endothelial nitric oxide handling. Apocynin supplies the first, resveratrol the second. The pairing rests on cell and animal models with no human combination evidence. Concentrations used in vitro are not a guide to intake.
Superoxide arises both from the membrane NADPH oxidase complex and from electron leak in the mitochondrial chain. Apocynin is used against the first, while ubiquinol participates in the second as an electron carrier and a lipid-phase antioxidant. Covering distinct sources is a coherent formulation logic. It has not been measured as a combination in people.
Nitrate from beetroot is reduced along the nitrate to nitrite to nitric oxide route and supports normal endothelial signalling. Superoxide destroys nitric oxide almost as fast as it meets it, forming peroxynitrite. Lowering oxidase-derived superoxide therefore preserves nitric oxide that is already present, which is exactly why apocynin is used as a probe in microvascular studies. The mechanism is established; the combination as a supplement is untested.
Pine bark polyphenols are studied for effects on endothelial redox balance and nitric oxide availability, the same axis where apocynin is used as a mechanistic tool. Any combined effect is inference from separate literatures. No study has given both together.
Nothing specific on file for Apocynin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Apocynin actually does.
Apocynin is 4-hydroxy-3-methoxyacetophenone, also called acetovanillone, a small methoxyphenol closely related to vanillin in structure.
Superoxide reacts with nitric oxide at a near diffusion-limited rate to form peroxynitrite, which is why reducing oxidase-derived superoxide is used experimentally to test nitric oxide dependent vascular responses.
Apocynin occurs naturally in the roots of Picrorhiza kurroa and Apocynum cannabinum, the plants that gave the compound its name.
It behaves as a pro-drug rather than a direct inhibitor: peroxidase activity plus hydrogen peroxide oxidises it to a phenoxyl radical that dimerises to diapocynin or conjugates with glutathione, and those products carry the reported oxidase-blocking activity.
Where Apocynin comes from.
Almost all apocynin sold is made in a reactor from simple aromatic chemicals, because the plants it was named after contain very little of it. A newer method uses engineered microbes to do the same chemical step in water. Whatever the route, the finished material is the same pale crystalline powder and is checked against a reference sample.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Botanical routes start from Picrorhiza kurroa or Apocynum root. Synthetic routes start from guaiacol or from 3,4-dihydroxyacetophenone, both commodity aromatic chemicals.
Chemical synthesis reaches acetovanillone either by Friedel-Crafts acetylation of guaiacol or by selective O-methylation of one hydroxyl of 3,4-dihydroxyacetophenone. A published biotransformation route uses engineered whole cells with an O-methyltransferase to perform that same methylation in water at mild temperature.
Dried milled root is extracted with alcohol or an alcohol-water mixture, then concentrated. Apocynin is a minor constituent of the root, which is why isolated material is usually synthetic.
Crude material is recrystallised from alcohol or water-alcohol; laboratory-grade lots may be chromatographed. Purity is confirmed by melting point, HPLC and NMR against the reference structure.
The finished article is an off-white to pale crystalline solid, stored away from light and oxidants because the phenol couples to the dimer on oxidation.
Getting Apocynin from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In a rodent model of chemically induced liver injury, apocynin dosing was associated with lower oxidative stress, inflammatory and apoptotic markers in liver tissue; these are markers measured in animals, not clinical outcomes.Animal study. Ahmed et al., 2025 (BMC Pharmacology and Toxicology). PMID 41327398 ↗
- An engineered whole-cell biocatalyst converted 3,4-dihydroxyacetophenone into apocynin at high efficiency, describing a biotechnological production route rather than any effect in a body.In vitro study. Wang et al., 2025 (World Journal of Microbiology and Biotechnology). PMID 40804129 ↗
- Four weeks of vitamin D supplementation was reported to improve nitric oxide mediated microvascular responses; apocynin appears as a locally infused NADPH oxidase inhibitor used to interrogate the mechanism, not as the supplement being tested.Randomised trial. Wolf et al., 2020 (American Journal of Physiology: Heart and Circulatory Physiology). PMID 32857616 ↗
- An eight-day controlled high-dairy-cheese feeding pattern was associated with preserved cutaneous microvascular function under a high sodium load, with apocynin used as a mechanistic probe of oxidase-derived superoxide.Randomised trial. Alba et al., 2020 (The Journal of Nutrition). PMID 31504721 ↗
- Spirulina feeding was associated with preserved intestinal smooth muscle relaxation in animals fed an energy-dense diet, with oxidase-derived superoxide implicated through inhibitor experiments naming apocynin.Animal study. Alves Arruda et al., 2026 (Journal of Ethnopharmacology). PMID 41833761 ↗
- Innate immune signalling, microbiota and bile acids interacted locally in duodenal tissue development, with apocynin named among the pharmacological tools used in the experimental work.Animal study. Burgueño et al., 2026 (Cellular and Molecular Gastroenterology and Hepatology). PMID 41344439 ↗
- In a small pilot, creatine monohydrate supplementation and local NADPH oxidase inhibition were examined for effects on skeletal muscle microvascular blood flow; the sample was exploratory and apocynin served as the inhibitor probe.Open-label trial. Baker et al., 2025 (Pflugers Archiv). PMID 40447849 ↗
These are the studies our verdict leans on, chosen from the 7 we read for Apocynin. The full linked list is below.
The studies, linked.
6 sources behind our Apocynin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Placebo-controlled, Double-blinded, Randomized, Trial Using a Combination of Apocynin and Paeonol (APPA) for the Treatment of Knee OsteoarthritisClinicalTrials.gov ↗PHASE2 · 152 participants · Completed
- Clinical trialThe Effect of Antioxidants on Skin Blood Flow During Local HeatingClinicalTrials.gov ↗PHASE1 · 44 participants · Completed
- Clinical trialThe Effect of Local Antioxidant Therapy on Racial Differences in VasoconstrictionClinicalTrials.gov ↗PHASE1 · 24 participants · Completed
- ClinicalTrials.gov ↗
- Clinical trialHydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD PatientsClinicalTrials.gov ↗PHASE1 · 13 participants · Completed
- Clinical trialInhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild AsthmaticsClinicalTrials.gov ↗PHASE1 · 10 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.